Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

352 ARTÍCULOS , VIENDO DEL 151 AL 165

Spatial Dissociation of Atrophy and Hypophysiology in Alzheimer's Disease: Implications for Biomarkers

Dang A, Wang D, Towne JM, Seshadri S, Habes M, Fox PT.

Hum Brain Mapp. 2025 Nov;46(16):e70402. doi: 10.1002/hbm.70402.

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

Schöll M, Vrillon A, Ikeuchi T, Quevenco FC, Iaccarino L, Vasileva-Metodiev SZ, Burnham SC, Hendrix J, Epelbaum S, Zetterberg H, Palmqvist S.

J Prev Alzheimers Dis. 2025 Apr;12(4):100056. doi: 10.1016/j.tjpad.2024.100056. Epub 2025 Jan 14.

The influence of time-restricted eating/feeding on Alzheimer's biomarkers and gut microbiota

Gasmi M, Silvia Hardiany N, van der Merwe M, Martins IJ, Sharma A, Williams-Hooker R.

Nutr Neurosci. 2025 Feb;28(2):156-170. doi: 10.1080/1028415X.2024.2359868. Epub 2024 Jul 2.

The coupling of global brain activity and cerebrospinal fluid flow as a potential predictive marker of brain amyloid-β accumulation

Tanaka Y, Kamagata K, Saito Y, Takabayashi K, Iseki R, Uchida W, Andica C, Hagiwara A, Wada A, Akashi T, Abe O, Aoki S; Alzheimer’s Disease Neuroimaging Initiative.

J Prev Alzheimers Dis. 2025 Sep;12(8):100228. doi: 10.1016/j.tjpad.2025.100228. Epub 2025 Jun 13.

The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease

Daksh R, Mathew MS, Bosco AM, Sojan C, Tom AA, Bojja SL, Nampoothiri M.

Biochem Biophys Res Commun. 2025 Mar 25;754:151526. doi: 10.1016/j.bbrc.2025.151526. Epub 2025 Feb 21.

From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape

Bougea A, Debasa-Mouce M, Gulkarov S, Castro-Mosquera M, Reiss AB, Ouro A.

Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.

Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study

Boccalini C, Peretti DE, Scheffler M, Mu L, Griffa A, Testart N, Allali G, Prior JO, Ashton NJ, Zetterberg H, Blennow K, Frisoni GB, Garibotto V.

Alzheimers Res Ther. 2025 Feb 18;17(1):46. doi: 10.1186/s13195-025-01684-z.

Disclosure of Alzheimer's disease blood-based biomarker results in a primary care setting: Opportunities and challenges

Bolton CJ, Rostamzadeh A, Chin N, Fowler NR, Heidebrink J, Rahman-Fillipiak A, Romano RR 3rd, Clark LR; Advisory Group on Risk Evidence Education in Dementia (AGREEDementia).

J Prev Alzheimers Dis. 2025 Nov;12(9):100310. doi: 10.1016/j.tjpad.2025.100310. Epub 2025 Jul 25.

Detection of Alzheimer's Disease Neuropathology in Chronic Kidney Disease: Current State and Future Directions

Gupta A, Mielke MM, Tariot PN.

J Am Geriatr Soc. 2025 Oct;73(10):2995-3001. doi: 10.1111/jgs.19554. Epub 2025 Jun 17.

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.

Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.

Exosomal Non-Coding RNAs as Potential Biomarkers for Alzheimer's Disease: Advances and Perspectives in Translational Research

Titze-de-Almeida SS, Marina CL, Ramos MV, Silva LDDS, Brandão PRP, Bispo DDC, Von Glehn F, Titze-de-Almeida R.

Int J Mol Sci. 2025 Aug 25;26(17):8246. doi: 10.3390/ijms26178246.

Elevated D-dimer levels after lecanemab infusions: a case report

Zou M, Xu SS, Zhu SG, Yuan CX, Huang JF, Zhu JH, Zhang X, Wang JY.

BMC Geriatr. 2025 Sep 29;25(1):742. doi: 10.1186/s12877-025-06445-z.

Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers

Arslan B, Zetterberg H, Ashton NJ.

J Alzheimers Dis. 2025 Nov;108(1):75-78. doi: 10.1177/13872877251375101. Epub 2025 Sep 9.

Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 Conference

Falgàs N, Maure-Blesa L, Ances B, Flores-Aguilar L, Hartley S, Hassenstab J, Iulita MF, Janicki M, Koenig K, Lao P, Levin J, McDade E, Meijer L, Rafii MS, Snyder HM, Sánchez-Valle R, Fortea J; DSAD‐ADAD conference group; Arriola Infante J, Balasa M, Barroeta I, Barthelemy R N, Bejanin A, Benejam B, Bosch B, Bradshaw A, Carmona-Iragui M, Cohen A, Comas Albertí A, Csincsik L, Cuello AC, Del Hoyo Soriano L, Dijkstra J, Edwards N, Giménez S, Gonzalez-Ortiz F, Gordon B, Gutiérrez Fernández S, Handen B, Jacob C, Johnson E, Johansson C, Lladó A, Lleó A, Morabito S, Morcillo-Nieto AO, Montoliu-Gaya L, Okafor M, Pérez-Millan A, Potier MC, Ringman J, Rodríguez-Baz Í, Rubenstein E, Ryan NS, Strydom A, Vaqué-Alcázar L, Vermunt L, Videla Toro L, Zaman S.

Alzheimers Dement. 2025 Jul;21(7):e70309. doi: 10.1002/alz.70309.

Randomized phase 2a trial assessing a novel septin molecular glue in Alzheimer's disease

Nuytten M, Voets M, Debroux E, Princen K, Pringels L, Fivaz M, Byl E, Ramael S, De Witte K, Boada M, Morató X, Tartari JP, Lafuente A, Macias EF, Matias-Guiu JA, Vijverberg E, Teunissen CE, Anderer P, Staggs V, Hayman V, Corbett A, Ballard C, Harrison JE, Windisch M, Westman AB, Zetterberg H, Dickson S, Mallinckrodt C, Hendrix S, Cummings J, Griffioen G.

Alzheimers Dement. 2025 Sep;21(9):e70537. doi: 10.1002/alz.70537.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias